References
Spec Sheet

Proven benefits for you and your patients:

Outstanding rotational stability with median rotation 1.1° (range:0.0°-5.0°)1

Glistening-free hydrophobic IOL material for enhanced clarity2,3,4,5

Proprietary aspheric design to improve image quality6

Active oxygen processing treatment, a smooth surface, and square optic edge to reduce PCO3,7,8,9,10,11,12,13

Raising the bar

Maximum rotation values observed in the first week following surgery1,2

Reliable outcomes through outstanding rotational stability

Compared with AcrySof®, Tecnis®, and enVista®,* Vivinex™ demonstrated the least

amount of rotation in the first week post-surgery.1,2

Setting the standard for rotational stability

Vivinex™ had no rotations more than 5° from the initial axis up to 6 months post-operation1,2 compared with Acrysof®, Tecnis®, and enVista®.*

Glistening-free clarity

In vitro glistening formation at 14x magnification2

Vivinex™ is rated glistening-free with 97.0% of lenses demonstrating <10 glistenings per 10mm x 2mm field and showing significantly less glistenings than AcrySof IQ SN60WF* (p<0.0001).3

More than meets the eye

Watch how Vivinex™ improves image quality and reduces coma compared with other traditional negative aspheric IOLs.1

 

What features of an IOL limit PCO?

Vivinex™ is made from a novel hydrophobic acrylic, using a proprietary manufacturing process that includes a unique, active oxygen posterior surface treatment

Combined with its square edge design and smooth, regular IOL surface, it has been demonstrated to provide a low incidence of PCO in several studies.1-6

What features of an IOL limit PCO?

Watch how Vivinex™ improves image quality and reduces coma compared with other traditional negative aspheric IOLs.1

Are you interested in clinical proof?

These results confirm low occurrence of PCO in both IOL groups and significantly lower PCO incidence with Vivinex™ compared to AcrySof® IQ.

Vivinex™ is made from a novel hydrophobic acrylic, using a proprietary manufacturing process that includes a unique, active oxygen posterior surface treatment. Combined with its square edge design and smooth, regular IOL surface, it has been demonstrated to provide a low incidence of PCO in several studies.1-8